Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $86.2200 (3.72%) ($83.3500 - $87.0600) on Tue. Nov. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.5% (three month average) | RSI | 31 | Latest Price | $86.2200(3.72%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -5.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.25% in a week (0% probabilities). VIXM(-22%) UUP(-17%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.25% (StdDev 2.5%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $68.98(-20%) | Inflection Point | Yes | Resistance Level | $91.06 | 5 Day Moving Average | $83.98(2.67%) | 10 Day Moving Average | $84.16(2.45%) | 20 Day Moving Average | $91.06(-5.32%) | To recent high | -27.6% | To recent low | 7.3% | Market Cap | $1.386b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |